Geneva, April 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600121843) titled 'A Preliminary Case Study to Evaluate the Efficacy and Safety of Talquetamab in Patients with Refractory Generalized Myasthenia Gravis' on April 3.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: The First Affiliated Hospital of Chongqing Medical University
Condition:
Myasthenia Gravis
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-04-10
Target Sample Size: Experimental group:2;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=314263
Published by HT Digital Content Services with permission from...